For more information on the results of the survey or to conduct an interview with a patient living with depression, GeneSight® expert or DBSA expert, please email or call:
| Sharvari Dayal | |
| sharvari.dayal@myriad.com | |
| (330) 354-7150 |
For more information on the results of the survey or to conduct an interview with a patient living with depression, GeneSight® expert or DBSA expert, please email or call:
| Sharvari Dayal |
| sharvari.dayal@myriad.com |
| (330) 354-7150 |
Multimedia Release
Understanding Depression
Get the B-roll video package
Photo Gallery
Amanda Lange smiles at her infant son. Her depression had kept her from enjoying her life, but with support from her family, she sought treatment. She found relief after working with her doctor, who ordered the GeneSight Psychotropic test.
Michael Jablonski, Ph.D., M.S., vice president of medical affairs for the GeneSight test at Myriad Genetics, reviews a GeneSight Psychotropic report. The GeneSight Mental Health Monitor national survey found that 7 in 10 would feel “hopeful” if their doctor recommended genetic testing as part of their treatment plan.
Amanda Lange swabs her cheek to complete the GeneSight Psychotropic test. The test was ordered by her doctor to get information about which medications may require dose adjustments, may be less likely to work, or may have an increased risk of side effects based on her genetic makeup. In a new nationwide poll, the GeneSight Mental Health Monitor found 7 in 10 adults with depression would feel “hopeful” if their doctor recommended genetic testing as part of their treatment plan.
Amanda Lange plays with her daughter. After battling depression, she leaned on her family for support in seeking the help she needed to get back to feeling like herself.
Experiencing Depression
We also have a limited number of physical kits that include elements for you to experience some symptoms of depression to share with your viewers/readers/listeners and bring the story to life. If you are interested in a kit, please email the media contacts listed above.
About the GeneSight Test
The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for certain medications commonly prescribed for depression, anxiety and other psychiatric conditions. The GeneSight test can help inform doctors about how a patient’s genes that may impact how they metabolize or respond to certain psychiatric medications. It has been given to more than one million patients by tens of thousands of clinicians to provide genetic information that is unique to each patient. The GeneSight test supplements other information considered by a doctor as part of a comprehensive medical assessment. Learn more at GeneSight.com.
About Depression and Bipolar Support Alliance
The Depression and Bipolar Support Alliance (DBSA) is a not-for-profit, 501(c)(3) organization that provides hope, help, support and education to serve the estimated 21 million people throughout the U.S. who live with mood disorders. Programs and resources are offered through our website, dbsalliance.org, and through our 500+ support groups and 150+ chapters across the country.
DBSA emphasizes the value of peer support as a crucial resource for wellness. The term peer describes someone who lives with a mood disorder. DBSA believes in the strength and resilience of each person and supports the individual’s right to create his/her/their own path to wellness. DBSA also serves caregivers, families and friends of people living with mood disorders because family and social support are central to wellness.
About Depression and Bipolar Support Alliance
The Depression and Bipolar Support Alliance (DBSA) is a not-for-profit, 501(c)(3) organization that provides hope, help, support and education to serve the estimated 21 million people throughout the U.S. who live with mood disorders. Programs and resources are offered through our website, dbsalliance.org, and through our 500+ support groups and 150+ chapters across the country.
DBSA emphasizes the value of peer support as a crucial resource for wellness. The term peer describes someone who lives with a mood disorder. DBSA believes in the strength and resilience of each person and supports the individual’s right to create his/her/their own path to wellness. DBSA also serves caregivers, families and friends of people living with mood disorders because family and social support are central to wellness.
The GeneSight Mental Health Monitor is a nationwide survey of U.S. adults conducted by ACUPOLL Precision Research, Inc. in March 2021. The survey was conducted among a statistically representative sample of U.S. adults age 18+, including a U.S. representative sample of adults who have been diagnosed with depression. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.